Back

Future direction for research in platelet P2Y12 iinhibition in acute coronary syndromes

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Rapid platelet P2Y12 iinhibition in acute coronary syndromes Thrombosis and platelets ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Kurt Huber

Sigmund Freud University Vienna, Vienna (Austria)

4 More presentations in this session

Presentation thumbnail
State of the art in platelet P2Y12 iinhibition in acute coronary syndromes
Professor J. Collet (Paris, FR)
Slides Video
Presentation thumbnail
Greater efficacy of prasugrel and ticagrelor administered at first medical contact compared to a switching strategy during the first hours after primary percutaneous coronary intervention
Doctor A. Marcano Fernandez (L'hospitalet De Llobregat, ES)
Abstract Slides Video
Presentation thumbnail
Chewing versus traditional swallowing of ticagrelor to accelerate platelet inhibition in acute coronary syndrome- the CHEERS study
Doctor E. Asher (Jerusalem, IL)
Abstract Slides Video
Presentation thumbnail
Cangrelor compared with clopidogrel in patients with prior myocardial infarction - Insights from the CHAMPION trials
Doctor A. Eisen (Petah Tikva, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Rapid platelet P2Y12 iinhibition in acute coronary syndromes

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources